Skip to main content
. 2020 Jan 25;2020:7190828. doi: 10.1155/2020/7190828

Table 3.

Determinants of a short bleeding time (BT, the lower quartile) in coronary artery disease (CAD) patients and controls.

Variable CAD patients (BT < 202 sec) Controls (BT < 324 sec)
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
OR (95% CI) p OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age (y) 1.02 (0.97-1.08) 0.41 1.01 (0.95-1.08) 0.69 1.20 (1.12-1.28) <0.001 1.10 (1.00-1.21) 0.06
Current smoking 1.34 (0.63-2.86) 0.45 1.50 (0.57-3.99) 0.42 0.53 (0.23-1.22) 0.13 0.54 (0.18-1.62) 0.27
Diabetes 0.77 (0.27-2.24) 0.64 1.24 (0.31-4.87) 0.76
Anemia 1.41 (0.53-3.74) 0.49 1.11 (0.30-4.07) 0.87 1.45 (0.47-4.46) 0.52 1.61 (0.37-7.10) 0.53
ASA treatment 0.62 (0.26-1.48) 0.28 0.42 (0.12-1.44) 0.17
Statin treatment 2.24 (1.01-4.97) 0.048 4.34 (1.44-12.97) 0.01
Platelet count in the lower quartile (≤205 and ≤205 × 103/μL) 0.18 (0.05-0.63) 0.007 0.22 (0.05-0.92) 0.038 0.37 (0.13-1.02) 0.05 0.36 (0.10-1.32) 0.12
FVIII > 150% 1.11 (0.53-2.32) 0.79 0.65 (0.23-1.83) 0.41 1.96 (0.90-4.24) 0.09 0.66 (0.21-2.05) 0.48
CLT in the lower quartile (≤74 and <68 min) 0.73 (0.30-1.77) 0.49 1.02 (0.33-3.16) 0.97 0.93 (0.39-2.20) 0.87 2.53 (0.77-8.33) 0.13
K s in the lower quartile (<6.1 and ≤8 × 10−9 cm2) 4.32 (1.94-9.60) <0.001 3.35 (1.15-9.73) 0.027 21.27 (8.47-53.44) <0.001 10.02 (2.45-40.97) 0.001
HRG in the lower quartile (≤28 and ≤56.9 μg/mL) 9.23 (4.04-21.07) <0.001 9.19 (3.50-24.29) <0.001 3.11 (1.40-6.87) 0.005 1.11 (0.36-3.41) 0.85

For a list of abbreviations, see Tables 1 and 2. Cutoffs for CAD patients and controls, respectively, are given.